MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma
Author:
Open Access
- 1 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (26) , e16051
Abstract
MiR-101plays an important role in tumorigenesis. The aim of this study was to estimate diagnostic potential of serummiR-101in bladder cancer.Serum level ofmiR-101in 122 bladder cancer patients and 110 healthy volunteers was detected using quantitative real-time polymerase chain reaction method. The association betweenmiR-101expression and clinicopathological characteristic was analyzed via χ2test. Then receiver operating characteristic (ROC) curve was plotted to evaluate diagnostic value of serummiR-101in bladder cancer.MiR-101expression was statistically down-regulated in bladder cancer patients compared to healthy controls.MiR-101expression was significantly associated with TNM stage (P = .019), pathological grade (P = .006) and lymph node metastasis (P = .010). ROC analysis suggested thatmiR-101had high value in discriminating between bladder cancer patients and healthy individuals with an AUC value of 0.884. The cut-off value for serummiR-101in bladder cancer diagnosis was 1.645, with a sensitivity of 82.0% and a specificity of 80.9%.MiR-101is decreased in bladder cancer patients, and shows negative association with aggressive clinical characteristics.MiR-101may serve as a bio-marker in diagnosing bladder cancer.Keywords
This publication has 31 references indexed in Scilit:
- Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinomaCancer Biology & Therapy, 2014
- Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosisMedical Science Monitor, 2014
- Diversifying microRNA sequence and functionNature Reviews Molecular Cell Biology, 2013
- MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-MetBiochemical and Biophysical Research Communications, 2013
- miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)Journal of Biological Chemistry, 2013
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significanceMedical Oncology, 2011
- Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase‐2 in patients with bladder cancerIUBMB Life, 2010
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 1993